Talaris Therapeutics to Present at the 2022 Cell & Gene Meeting on the Mesa

Rhea-AI Summary

Talaris Therapeutics (Nasdaq: TALS), a late-stage cell therapy company, announces CEO Scott Requadt's presentation at the 2022 Cell & Gene Meeting on the Mesa, scheduled for October 11-13, 2022, in Carlsbad, California. This event will be livestreamed globally. A pre-recorded presentation will be available on-demand starting October 11. Talaris focuses on developing transformative therapies for solid organ transplantation and severe immune disorders, with corporate offices in Boston, a cell processing facility in Louisville, and research operations in Houston.

BOSTON and LOUISVILLE, Ky., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc. (Nasdaq: TALS), a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation and severe immune and blood disorders, today announced that Scott Requadt, Chief Executive Officer of Talaris, will present at the 2022 Cell & Gene Meeting on the Mesa being held October 11-13, 2022 in Carlsbad, California and livestreamed globally. In addition, members from the management team will also be in attendance.

A pre-recorded presentation will be available on-demand starting Tuesday, October 11, 2022. Please visit https://meetingonthemesa.com for full information including registration.

About Talaris Therapeutics
Talaris Therapeutics, Inc. is a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation and severe immune and blood disorders. Talaris maintains corporate offices in Boston, MA, its cell processing facility in Louisville, KY, and additional research operations in Houston, TX.

Media Contact
Lisa Raffensperger
Ten Bridge Communications
lisa@tenbridgecommunications.com
(617) 903-8783

Investor Contact
Chris Brinzey
ICR Westwicke
chris.brinzey@westwicke.com
(339) 970-2843

FAQ

What is Talaris Therapeutics presenting at the Cell & Gene Meeting on the Mesa?

Talaris Therapeutics will present insights on their innovative therapies for solid organ transplantation and immune disorders.

When is the 2022 Cell & Gene Meeting on the Mesa?

The event is scheduled for October 11-13, 2022.

Where is the Cell & Gene Meeting on the Mesa taking place?

The meeting will be held in Carlsbad, California.

How can I access Talaris' presentation?

A pre-recorded presentation will be available on-demand starting October 11, 2022, on the event's website.

What is Talaris Therapeutics focused on?

Talaris is focused on developing cell therapies for solid organ transplantation and severe immune and blood disorders.